|
| 36795625 | Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023. | MMWR Morb Mortal Wkly Rep | 2023 |
| 37490025 | Mortality patterns over a 10-year period in Kibera, an urban informal settlement in Nairobi, Kenya, 2009-2018. | Glob Health Action | 2023 |
| 38073666 | Prevalence and Missed Cases of Respiratory Distress Syndrome Disease Amongst Neonatal Deaths Enrolled in the Kenya Child Health and Mortality Prevention Surveillance Network (CHAMPS) Program Between 2017 and 2021. | Glob Pediatr Health | 2023 |
| 37901408 | Correcting for measurement error in assessing gestational age in a low-resource setting: a regression calibration approach. | Front Med (Lausanne) | 2023 |
| 37883602 | The epidemiology of fecal carriage of nontyphoidal Salmonella among healthy children and adults in three sites in Kenya. | PLoS Negl Trop Dis | 2023 |
| 37089780 | Effectiveness of COVID-19 mRNA Vaccines in Preventing COVID-19-Associated Outpatient Visits and Hospitalizations Among American Indian and Alaska Native Persons, January-November 2021: A Test-Negative Case-Control Analysis Using Surveillance Data. | Open Forum Infect Dis | 2023 |
| 37253442 | Dynamic Incidence of Typhoid Fever over a 10-Year Period (2010-2019) in Kibera, an Urban Informal Settlement in Nairobi, Kenya. | Am J Trop Med Hyg | 2023 |
| 37213428 | Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Periods. | Open Forum Infect Dis | 2023 |
| 37074444 | Shigella in Africa: New Insights From the Vaccine Impact on Diarrhea in Africa (VIDA) Study. | Clin Infect Dis | 2023 |
| 37074442 | Exploring Survey-Based Water, Sanitation, and Animal Associations With Enteric Pathogen Carriage: Comparing Results in a Cohort of Cases With Moderate-to-Severe Diarrhea to Those in Controls in the Vaccine Impact on Diarrhea in Africa (VIDA) Study, 2015-2018. | Clin Infect Dis | 2023 |
| 37074443 | Clinical and Epidemiologic Features of Cryptosporidium-Associated Diarrheal Disease Among Young Children Living in Sub-Saharan Africa: The Vaccine Impact on Diarrhea in Africa (VIDA) Study. | Clin Infect Dis | 2023 |
| 37074440 | Management of Diarrhea in Young Children in Sub-Saharan Africa: Adherence to World Health Organization Recommendations During the Global Enteric Multisite Study (2007-2011) and the Vaccine Impact of Diarrhea in Africa (VIDA) Study (2015-2018). | Clin Infect Dis | 2023 |
| 37074441 | Norovirus Disease Among Children <5 Years in 3 Sub-Saharan African Countries: Findings From the Vaccine Impact on Diarrhea in Africa (VIDA) Study, 2015-2018. | Clin Infect Dis | 2023 |
| 37074439 | Prevalence, Clinical Severity, and Seasonality of Adenovirus 40/41, Astrovirus, Sapovirus, and Rotavirus Among Young Children With Moderate-to-Severe Diarrhea: Results From the Vaccine Impact on Diarrhea in Africa (VIDA) Study. | Clin Infect Dis | 2023 |
| 37074438 | Survey-Based Assessment of Water, Sanitation, and Animal-Associated Risk Factors for Moderate-to-Severe Diarrhea in the Vaccine Impact on Diarrhea in Africa (VIDA) Study: The Gambia, Mali, and Kenya, 2015-2018. | Clin Infect Dis | 2023 |
| 37074437 | Stunting Following Moderate-to-Severe Diarrhea Among Children Aged <5 Years in Africa Before and After Rotavirus Vaccine Introduction: A Comparison of the Global Enteric Multicenter Study and the Vaccine Impact on Diarrhea in Africa (VIDA) Study. | Clin Infect Dis | 2023 |
| 37074436 | Etiology, Presentation, and Risk Factors for Diarrheal Syndromes in 3 Sub-Saharan African Countries After the Introduction of Rotavirus Vaccines From the Vaccine Impact on Diarrhea in Africa (VIDA) Study. | Clin Infect Dis | 2023 |
| 37074435 | Histo-Blood Group Antigen Null Phenotypes Associated With a Decreased Risk of Clinical Rotavirus Vaccine Failure Among Children <2 Years of Age Participating in the Vaccine Impact on Diarrhea in Africa (VIDA) Study in Kenya, Mali, and the Gambia. | Clin Infect Dis | 2023 |
| 37074433 | Epidemiology of Enteroaggregative, Enteropathogenic, and Shiga Toxin-Producing Escherichia coli Among Children Aged <5 Years in 3 Countries in Africa, 2015-2018: Vaccine Impact on Diarrhea in Africa (VIDA) Study. | Clin Infect Dis | 2023 |
| 37074432 | Giardia Detection and Codetection With Other Enteric Pathogens in Young Children in the Vaccine Impact on Diarrhea in Africa (VIDA) Case-Control Study: 2015-2018. | Clin Infect Dis | 2023 |
| 37074429 | Prevalence of Salmonella in Stool During the Vaccine Impact on Diarrhea in Africa (VIDA) Study, 2015-2018. | Clin Infect Dis | 2023 |
| 37074430 | Moderate-to-Severe Diarrhea and Stunting Among Children Younger Than 5 Years: Findings From the Vaccine Impact on Diarrhea in Africa (VIDA) Study. | Clin Infect Dis | 2023 |
| 37074427 | Antibiotic-Prescribing Practices for Management of Childhood Diarrhea in 3 Sub-Saharan African Countries: Findings From the Vaccine Impact on Diarrhea in Africa (VIDA) Study, 2015-2018. | Clin Infect Dis | 2023 |
| 37026401 | Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents. | Pediatrics | 2023 |
| 34741818 | Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data. | Lancet | 2022 |
| 35511708 | Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35709220 | Point-prevalence survey of antibiotic use at three public referral hospitals in Kenya. | PLoS One | 2022 |
| 35613039 | Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron. | N Engl J Med | 2022 |
| 35403695 | Comparable Pregnancy Outcomes for HIV-Uninfected and HIV-Infected Women on Antiretroviral Treatment in Kenya. | J Infect Dis | 2022 |
| 35758873 | Effectiveness of Coronavirus Disease 2019 (COVID-19) mRNA Vaccines Against Infection During an Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta (B.1.351) Variant in a Skilled Nursing Facility: Virginia, March-April 2021. | Clin Infect Dis | 2022 |
| 35599037 | Development of effective messages to promote maternal immunization in Kenya. | Vaccine | 2022 |
| 35358170 | Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35560036 | Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance. | JAMA | 2022 |
| 35385875 | mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients. | J Infect Dis | 2022 |
| 36566323 | Prevalence of colonization with multidrug-resistant bacteria in communities and hospitals in Kenya. | Sci Rep | 2022 |
| 36454688 | Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36100910 | Prevalence of microcephaly and Zika virus infection in a pregnancy cohort in Kenya, 2017-2019. | BMC Med | 2022 |
| 36156146 | Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States. | JAMA Netw Open | 2022 |
| 36007074 | Molecular characterization of circulating Salmonella Typhi strains in an urban informal settlement in Kenya. | PLoS Negl Trop Dis | 2022 |
| 35157002 | Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance. | JAMA | 2022 |
| 35239634 | Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35176007 | Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35085224 | Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35060999 | Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants. | JAMA | 2022 |
| 34967121 | Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021. | Am J Transplant | 2022 |
| 34932114 | Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021. | J Infect Dis | 2022 |
| 35083482 | Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Among Incarcerated People in California State Prisons: Retrospective Cohort Study. | Clin Infect Dis | 2022 |
| 35264324 | Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. | BMJ | 2022 |
| 35081612 | Identifying and Alleviating Bias Due to Differential Depletion of Susceptible People in Postmarketing Evaluations of COVID-19 Vaccines. | Am J Epidemiol | 2022 |
| 32777036 | Investigating the Meat Pathway as a Source of Human Nontyphoidal Salmonella Bloodstream Infections and Diarrhea in East Africa. | Clin Infect Dis | 2021 |